Postpartum depression: identification, screening, and treatment.
Depression during the postpartum period is a significant public health concern, affecting 8%-15% of women and resulting in considerable morbidity for women, and their infants and families. Risk, prevalence, and distinguishing features of postpartum mood disorders are provided. Anxiety and depression frequently co-occur, suggesting symptoms of anxiety should also be attended to when screening for postpartum depression. Recommendations include the use of a brief, valid screening instrument as a routine clinical practice and the unique role of the obstetrician/gynecologist, pediatrician, and family practice physician in identification and referral. A summary of evidence-based treatment options for postpartum depression, along with current information about psychotropic medication, is provided to assist in risk-benefit analyses and decision making with patients.
Perfetti
Jennifer
J
University of Wisconsin Medical School, Madison, 53719, USA.
Clark
Roseanne
R
Fillmore
Capri-Mara
CM
D000928:Antidepressive Agents / Q000627:therapeutic use; D001942:Breast Feeding; D019052:Depression, Postpartum / Q000175:diagnosis* / Q000628:therapy*; D005260:Female; D006801:Humans; D007223:Infant; D008403:Mass Screening; D011247:Pregnancy; D011569:Psychiatric Status Rating Scales; D011613:Psychotherapy
D000928:Antidepressive Agents